Invention Grant
- Patent Title: Combination therapy for treatment of hematological diseases
-
Application No.: US16670289Application Date: 2019-10-31
-
Publication No.: US11324749B2Publication Date: 2022-05-10
- Inventor: Albert Assad
- Applicant: Incyte Corporation
- Applicant Address: US DE Wilmington
- Assignee: Incyte Corporation
- Current Assignee: Incyte Corporation
- Current Assignee Address: US DE Wilmington
- Agency: Fish & Richardson P.C.
- Main IPC: A61K31/519
- IPC: A61K31/519 ; A61P35/00 ; A61K31/4015 ; A61K31/454 ; A61K31/573
Abstract:
The present application relates to treatment of a hematological disease selected from leukemia, lymphoma, and multiple myeloma in a patient in need thereof, comprising administering to the patient: (a) a therapeutically effective amount of a selective JAK1 inhibitor; (b) a therapeutically effective amount of an immunomodulatory agent, and (c) a therapeutically effective amount of a steroid.
Information query
IPC分类:
